RAGE signaling sustains inflammation and promotes tumor development

Journal of Experimental Medicine

Volumn 205, Issue 2, 2008, Pages 275-285

  Gebhardt, Christoffer ^a,b   Riehl, Astrid ^a   Durchdewald, Moritz ^a   Németh, Julia ^a   Fürstenberger, Gerhard ^a   Müller Decker, Karin ^a   Enk, Alexander ^b   Arnold, Bernd ^a   Bierhaus, Angelika ^b   Nawroth, Peter P ^b   Hess, Jochen ^a   Angel, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL INFILTRATION; CHIMERA; ENDOTHELIUM CELL; EPIDERMIS HYPERPLASIA; FEMALE; GLYCATION; IMMUNOCOMPETENT CELL; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; TUMOR PROMOTION; UPREGULATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; INFLAMMATION; MACROPHAGE INFLAMMATORY PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 39549098128     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20070679     Document Type: Article

References (35)

1. Hanahan, D., and R.A. Weinberg. 2000. The hallmarks of cancer. Cell. 100:57-70.
2. DiGiovanni, J. 1992. Multistage carcinogenesis in mouse skin. Pharmacol. Ther. 54:63-128.
3. Coussens, L.M., and Z. Werb. 2002. Inflammation and cancer. Nature. 420:860-867.
4. Balkwill, F., K.A. Charles, and A. Mantovani. 2005. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 7:211-217.
5. de Visser, K.E., A. Eichten, and L.M. Coussens. 2006. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer. 6:24-37.
6. Furstenberger, G., and A. Kopp-Schneider. 1995. Malignant progression of papillomas induced by the initiation-promotion protocol in NMRI mouse skin. Carcinogenesis. 16:61-69.
7. Moore, R.J., D.M. Owens, G. Stamp, C. Arnott, F. Burke, N. East, H. Holdsworth, L. Turner, B. Rollins, M. Pasparakis, et al. 1999. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat. Med. 5:828-831.
8. Schmidt, A.M., S.D. Yan, S.F. Yan, and D.M. Stern. 2001. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108:949-955.
9. Bierhaus, A., P.M. Humpert, M. Morcos, T. Wendt, T. Chavakis, B. Arnold, D.M. Stern, and P.P. Nawroth. 2005. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83:876-886.
10. Liliensiek, B., M.A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper, S. Hofer, J. Plachky, H.J. Grone, F.C. Kurschus, A.M. Schmidt, et al. 2004. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 113:1641-1650.
11. Gebhardt, C., J. Nemeth, P. Angel, and J. Hess. 2006. S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol. 72:1622-1631.
12. Eferl, R., and E.F. Wagner. 2003. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer. 3:859-868.
13. Hsu, T.C., M.R. Young, J. Cmarik, and N.H. Colburn. 2000. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic. Biol. Med. 28:1338-1348.
14. Karin, M., and F.R. Greten. 2005. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5:749-759.
15. Taguchi, A., D.C. Blood, G. del Toro, A. Canet, D.C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, et al. 2000. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature. 405:354-360.
16. Tiano, H.F., C.D. Loftin, J. Akunda, C.A. Lee, J. Spalding, A. Sessoms, D.B. Dunson, E.G. Rogan, S.G. Morham, R.C. Smart, and R. Langenbach. 2002. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res. 62:3395-3401.
17. Shanmugam, N., Y.S. Kim, L. Lanting, and R. Natarajan. 2003. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J. Biol. Chem. 278:34834-34844.
18. Bianchi, R., C. Adami, I. Giambanco, and R. Donato. 2007. S100B binding to RAGE in microglia stimulates COX-2 expression. J. Leukoc. Biol. 81:108-118.
19. Muller-Decker, K., G. Neufang, I. Berger, M. Neumann, F. Marks, and G. Furstenberger. 2002. Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc. Natl. Acad. Sci. USA. 99:12483-12488.
20. Jamieson, T., D.N. Cook, R.J. Nibbs, A. Rot, C. Nixon, P. McLean, A. Alcami, S.A. Lira, M. Wiekowski, and G.J. Graham. 2005. The chemokine receptor D6 limits the inflammatory response in vivo. Nat. Immunol. 6:403-411.
21. Nibbs, R.J., D.S. Gilchrist, V. King, A. Ferra, S. Forrow, K.D. Hunter, and G.J. Graham. 2007. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J. Clin. Invest. 117:1884-1892.
22. Pikarsky, E., and Y. Ben-Neriah. 2006. NF-kappaB inhibition: a double-edged sword in cancer? Eur. J. Cancer. 42:779-784.
23. Bierhaus, A., S. Schiekofer, M. Schwaninger, M. Andrassy, P.M. Humpert, J. Chen, M. Hong, T. Luther, T. Henle, I. Kloting, et al. 2001. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes. 50:2792-2808.
24. Gebhardt, C., U. Breitenbach, J.P. Tuckermann, B.T. Dittrich, K.H. Richter, and P. Angel. 2002. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Oncogene. 21:4266-4276.
25. Hofmann, M.A., S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, et al. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 97:889-901.
26. Andrassy, M., J. Igwe, F. Autschbach, C. Volz, A. Remppis, M.F. Neurath, E. Schleicher, P.M. Humpert, T. Wendt, B. Liliensiek, et al. 2006. Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am. J. Pathol. 169:1223-1237.
27. Zenz, R., R. Eferl, L. Kenner, L. Florin, L. Hummerich, D. Mehic, H. Scheuch, P. Angel, E. Tschachler, and E.F. Wagner. 2005. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature. 437:369-375.
28. Hiratsuka, S., A. Watanabe, H. Aburatani, and Y. Maru. 2006. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8:1369-1375.
29. Vogl, T., K. Tenbrock, S. Ludwig, N. Leukert, C. Ehrhardt, M.A. van Zoelen, W. Nacken, D. Foell, T. van der Poll, C. Sorg, and J. Roth. 2007. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13:1042-1049.
30. Orlova, V.V., E.Y. Choi, C. Xie, E. Chavakis, A. Bierhaus, E. Ihanus, C.M. Ballantyne, C.G. Gahmberg, M.E. Bianchi, P.P. Nawroth, and T. Chavakis. 2007. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 26:1129-1139.
31. Constien, R., A. Forde, B. Liliensiek, H.J. Grone, P. Nawroth, G. Hammerling, and B. Arnold. 2001. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis. 30:36-44.
32. Muller-Decker, K., G. Furstenberger, N. Annan, D. Kucher, A. Pohl-Arnold, B. Steinbauer, I. Esposito, S. Chiblak, H. Friess, P. Schirmacher, and I. Berger. 2006. Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice. Gastroenterology. 130:2165-2178.
33. Lumsden, J.M., J.A. Williams, and R.J. Hodes. 2003. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo. J. Immunol. 170:781-787.
34. Thomas-Ahner, J.M., B.C. Wulff, K.L. Tober, D.F. Kusewitt, J.A. Riggenbach, and T.M. Oberyszyn. 2007. Gender differences in UVB-induced skin carcinogenesis, inflammation, and DNA damage. Cancer Res. 67:3468-3474.
35. Gebhardt, C., U. Breitenbach, K.H. Richter, G. Furstenberger, C. Mauch, P. Angel, and J. Hess. 2005. c-Fos-dependent induction of the small ras-related GTPase Rab11a in skin carcinogenesis. Am. J. Pathol. 167:243-253.